<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00646126</url>
  </required_header>
  <id_info>
    <org_study_id>SUD 6/025</org_study_id>
    <nct_id>NCT00646126</nct_id>
  </id_info>
  <brief_title>Antimalarial Treatments for Clearing Low Density P. Falciparum and Its Impact on Malaria Transmission</brief_title>
  <official_title>Validation of the Use of Istope-Based Molecular Techniques for Malaria Control</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tropical Medicine Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>London School of Hygiene and Tropical Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>International Atomic Energy Agency</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tropical Medicine Research Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The malaria parasite Plasmodium falciparum remains at sub-patent level throughout the dry
      season in areas of seasonal malaria transmission. Targeting this parasite reservoir before
      the transmission season could be a good strategy for malaria control. We are conducting a
      randomized double blind placebo controlled mass drug administration trial in eight village to
      clear the dry season low level parasitaemia with an ultimate aim of controlling malaria in
      eastern Sudan.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2005</start_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Parsitaemia detected during the transmission season among dry season PCR negative persons in the intervention and control villages</measure>
    <time_frame>October to December 2006</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>1. Malaria prevalence during the transmission season 2. Frequency of mutation in drug resistance genes</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Plasmodium Falciparum</condition>
  <condition>Asymptomatic Parataemia</condition>
  <condition>Sub Patent Parasitaemia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1:Active comparator sulfadoxine-pyrimethamine plus artesunate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>2:placebo comparator</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sulfadoxine / Pyrimethamine (SP) plus artesunate (AS)</intervention_name>
    <description>Standard three day regimen</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo tablet similar to active drug in shape and size</intervention_name>
    <description>Dosage similar to active drug(standard three days regimen)</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All residents of the 8 villages

        Exclusion Criteria:

          -  Pregnancy

          -  History of allergy to sulfa drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Badria B El Sayed, PhD,MSc,BSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tropical Medicine Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tropical Medicine Research Institute</name>
      <address>
        <city>Khartoum</city>
        <zip>11111</zip>
        <country>Sudan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sudan</country>
  </location_countries>
  <verification_date>August 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2008</study_first_submitted>
  <study_first_submitted_qc>March 27, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 28, 2008</study_first_posted>
  <last_update_submitted>March 27, 2008</last_update_submitted>
  <last_update_submitted_qc>March 27, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 28, 2008</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malaria</mesh_term>
    <mesh_term>Parasitemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Artesunate</mesh_term>
    <mesh_term>Pyrimethamine</mesh_term>
    <mesh_term>Sulfadoxine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

